QUOTED. 18 September 2020. Ed Israelski.
Executive Summary
The US FDA has been skeptical about remote testing, but independent consultant (and former Abbott human factors director) Ed Israelski predicts the pandemic may bring a change.
“It seems to me that FDA will have to start accepting more remote tests for summative, otherwise things will come to a grinding halt in terms of new products – other than those that get emergency use authorizations.” — Ed Israelski, independent consultant
- Find out more: Human Factors Experts Forge Ahead With ‘Tricky’ In-Person Studies In The Age Of Coronavirus
Click here for a free trial of Medtech Insight